首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Discover oncology

缩写:

ISSN:N/A

e-ISSN:2730-6011

IF/分区:2.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引4657
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Wenping Ding,Shuo Liu,Huili Wang et al. Wenping Ding et al.
Background: Radiotherapy is essential after breast cancer surgery to prevent local recurrence. However, conventional fractionation involves extended treatment courses that can strain healthcare resources. In recent years,...
Fang Wei,Zi Qing Zhu,Yu Meng et al. Fang Wei et al.
Objective: Protein palmitoylation is a reversible lipid post-translational modification that influences protein stability, membrane association, and signal transduction. Increasing evidence indicates that dysregulated pal...
Adèle Meola,Romain Appay,Benoit Testud et al. Adèle Meola et al.
Objectives: We report the case of an adult-type diffuse glioma with spinal leptomeningeal dissemination, corresponding to a new molecularly methylation class, identified as "Adult-type diffuse high-grade glioma, IDH-wildt...
Yanfang Yang,Yaoyang Guo,Mingyu Zhu et al. Yanfang Yang et al.
To investigate the incidence, clinicopathological characteristics, and prognostic impact of SMARCA4 mutations in breast cancer, we conducted a retrospective cohort study using the MSK-CHORD database, enrolling 4,032 patients categorized int...
Jingna Wu,Bo Gao,Yunuo Zhang Jingna Wu
Background: Therapy for young women with breast cancer (YWBC) in early stage includes surgery, radiotherapy, and endocrinotherapy. Radiation exposure, including from postoperative radiotherapy (PORT), is known to increase...
Yirong Wang,Pengcheng Feng Yirong Wang
Objective: To investigate the prognostic value of a model based on ferroptosis-related long non-coding RNAs (lncRNAs) for patients with diffuse large B-cell lymphoma (DLBCL). ...
Kyoung Mi Sim,Supyong Hwang,Sojung Park et al. Kyoung Mi Sim et al.
Background: Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a main limitation in breast cancer therapy. Identifying effective sensitizers is crucial to overcome this hurdle. Cyclin-depende...
Pengcheng Fu,Dong Wen,Geliu Shuai et al. Pengcheng Fu et al.
Urological cancers exhibit significant sex differences in incidence, treatment response, and prognosis, with males generally showing higher morbidity and mortality. This review systematically summarizes the underlying molecular and clinical...
Shiwei Liu,Xueying Gao,Xuan Ye et al. Shiwei Liu et al.
B-cell lymphoma 6 (BCL6) is an attractive drug target for diffuse large B-cell lymphoma (DLBCL). This study aimed to create a lipid nanoparticle (LNP)-based peptide-proteolysis-targeting chimera (PROTAC), specifically BCL6-PROTAC, to develo...
Yifei Shi,Dong Niu,Chunhui Jin Yifei Shi
Ovarian cancer (OC) remains a malignancy characterized by obscure risk factors and unfavorable prognosis. While 3-tert-butyl-4-hydroxyanisole (3-BHA) is suspected of exerting toxic effects on ovarian health, the precise molecular mechanisms...